South Dakota
Phase 1 cancer trials in South Dakota
13 Phase 1 cancer studies are recruiting participants at sites in 1 city across South Dakota as of November 17, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every South Dakota city with a recruiting study
By research area: Breast Cancer (4), Lung Cancer (4), Lymphoma (2), Prostate Cancer (2), Melanoma (1).
Sioux Falls (13).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Breast cancer: recently updated in South Dakota
Basic details from each study's public record (the 12 most recently updated of 13). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Recruiting in
- Sioux Falls
- Registry record
- NCT06324357 · updated
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pliant Therapeutics, Inc.
- Recruiting in
- Sioux Falls
- Registry record
- NCT06270706 · updated
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Seagen, a wholly owned subsidiary of Pfizer
- Recruiting in
- Sioux Falls
- Registry record
- NCT04389632 · updated
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Day One Biopharmaceuticals, Inc.
- Recruiting in
- Sioux Falls
- Registry record
- NCT05377996 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in South Dakota on ClinicalTrials.gov.
Lung cancer: recently updated in South Dakota
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Sioux Falls
- Registry record
- NCT07227597 · updated
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Sioux Falls
- Registry record
- NCT04165070 · updated
A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
- Phase 1
- Ages 18 to 90
- All sexes
- Sponsor
- Amgen
- Recruiting in
- Sioux Falls
- Registry record
- NCT07037758 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in South Dakota on ClinicalTrials.gov.
Prostate cancer: recently updated in South Dakota
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Amgen
- Recruiting in
- Sioux Falls
- Registry record
- NCT04221542 · updated
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Amgen
- Recruiting in
- Sioux Falls
- Registry record
- NCT07493512 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in South Dakota on ClinicalTrials.gov.
Melanoma: recently updated in South Dakota
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- Phase 1/2
- From 6 months, up to 17 years
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Sioux Falls
- Registry record
- NCT02332668 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in South Dakota on ClinicalTrials.gov.
Lymphoma: recently updated in South Dakota
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Recruiting in
- Sioux Falls
- Registry record
- NCT04726241 · updated
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Phase 1/2
- From 6 months, up to 25 years
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Sioux Falls
- Registry record
- NCT06395103 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in South Dakota on ClinicalTrials.gov.
Ask about studies in South Dakota
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections